Self-efficacy of advanced cancer patients for participation in treatment-related decision-making in six European countries : the ACTION study
© 2023. The Author(s)..
PURPOSE: Many patients prefer an active role in making decisions about their care and treatment, but participating in such decision-making is challenging. The aim of this study was to explore whether patient-reported outcomes (quality of life and patient satisfaction), patients' coping strategies, and sociodemographic and clinical characteristics were associated with self-efficacy for participation in decision-making among patients with advanced cancer.
METHODS: We used baseline data from the ACTION trial of patients with advanced colorectal or lung cancer from six European countries, including scores on the decision-making participation self-efficacy (DEPS) scale, EORTC QLQ-C15-PAL questionnaire, and the EORTC IN-PATSAT32 questionnaire. Multivariable linear regression analyses were used to examine associations with self-efficacy scores.
RESULTS: The sample included 660 patients with a mean age of 66 years (SD 10). Patients had a mean score of 73 (SD 24) for self-efficacy. Problem-focused coping (B 1.41 (95% CI 0.77 to 2.06)), better quality of life (B 2.34 (95% CI 0.89 to 3.80)), and more patient satisfaction (B 7.59 (95% CI 5.61 to 9.56)) were associated with a higher level of self-efficacy. Patients in the Netherlands had a higher level of self-efficacy than patients in Belgium ((B 7.85 (95% CI 2.28 to 13.42)), whereas Italian patients had a lower level ((B -7.50 (95% CI -13.04 to -1.96)) than those in Belgium.
CONCLUSION: Coping style, quality of life, and patient satisfaction with care were associated with self-efficacy for participation in decision-making among patients with advanced cancer. These factors are important to consider for healthcare professionals when supporting patients in decision-making processes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
|---|---|
| Enthalten in: |
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer - 31(2023), 9 vom: 08. Aug., Seite 512 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yildiz, Berivan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Advanced cancer |
|---|
| Anmerkungen: |
Date Completed 09.08.2023 Date Revised 22.09.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00520-023-07974-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360519709 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360519709 | ||
| 003 | DE-627 | ||
| 005 | 20231226083203.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00520-023-07974-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1201.xml |
| 035 | |a (DE-627)NLM360519709 | ||
| 035 | |a (NLM)37552324 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yildiz, Berivan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Self-efficacy of advanced cancer patients for participation in treatment-related decision-making in six European countries |b the ACTION study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.08.2023 | ||
| 500 | |a Date Revised 22.09.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a PURPOSE: Many patients prefer an active role in making decisions about their care and treatment, but participating in such decision-making is challenging. The aim of this study was to explore whether patient-reported outcomes (quality of life and patient satisfaction), patients' coping strategies, and sociodemographic and clinical characteristics were associated with self-efficacy for participation in decision-making among patients with advanced cancer | ||
| 520 | |a METHODS: We used baseline data from the ACTION trial of patients with advanced colorectal or lung cancer from six European countries, including scores on the decision-making participation self-efficacy (DEPS) scale, EORTC QLQ-C15-PAL questionnaire, and the EORTC IN-PATSAT32 questionnaire. Multivariable linear regression analyses were used to examine associations with self-efficacy scores | ||
| 520 | |a RESULTS: The sample included 660 patients with a mean age of 66 years (SD 10). Patients had a mean score of 73 (SD 24) for self-efficacy. Problem-focused coping (B 1.41 (95% CI 0.77 to 2.06)), better quality of life (B 2.34 (95% CI 0.89 to 3.80)), and more patient satisfaction (B 7.59 (95% CI 5.61 to 9.56)) were associated with a higher level of self-efficacy. Patients in the Netherlands had a higher level of self-efficacy than patients in Belgium ((B 7.85 (95% CI 2.28 to 13.42)), whereas Italian patients had a lower level ((B -7.50 (95% CI -13.04 to -1.96)) than those in Belgium | ||
| 520 | |a CONCLUSION: Coping style, quality of life, and patient satisfaction with care were associated with self-efficacy for participation in decision-making among patients with advanced cancer. These factors are important to consider for healthcare professionals when supporting patients in decision-making processes | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Advanced cancer | |
| 650 | 4 | |a Coping | |
| 650 | 4 | |a Decision-making | |
| 650 | 4 | |a Self-efficacy | |
| 650 | 4 | |a Support | |
| 700 | 1 | |a Korfage, Ida J |e verfasserin |4 aut | |
| 700 | 1 | |a Deliens, Luc |e verfasserin |4 aut | |
| 700 | 1 | |a Preston, Nancy J |e verfasserin |4 aut | |
| 700 | 1 | |a Miccinesi, Guido |e verfasserin |4 aut | |
| 700 | 1 | |a Kodba-Ceh, Hana |e verfasserin |4 aut | |
| 700 | 1 | |a Pollock, Kristian |e verfasserin |4 aut | |
| 700 | 1 | |a Johnsen, Anna Thit |e verfasserin |4 aut | |
| 700 | 1 | |a van Delden, Johannes J M |e verfasserin |4 aut | |
| 700 | 1 | |a Rietjens, Judith A C |e verfasserin |4 aut | |
| 700 | 1 | |a van der Heide, Agnes |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer |d 1994 |g 31(2023), 9 vom: 08. Aug., Seite 512 |w (DE-627)NLM07487618X |x 1433-7339 |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2023 |g number:9 |g day:08 |g month:08 |g pages:512 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00520-023-07974-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 31 |j 2023 |e 9 |b 08 |c 08 |h 512 | ||